Financials Xiangyu Medical Co.,Ltd

Equities

688626

CNE100005394

Advanced Medical Equipment & Technology

End-of-day quote Shanghai S.E. Other stock markets 18:00:00 2024-05-14 EDT			5-day change	1st Jan Change
37.54 ^CNY	-1.57%		-6.48%	-29.56%

04-17	Xiangyu Medical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-02	Tranche Update on Xiangyu Medical Co.,Ltd's Equity Buyback Plan announced on August 10, 2023.	CI

Valuation

Fiscal Period: December	2021	2022	2023	2024	2025	2026
Capitalization ¹	9,107	5,028	8,375	5,898	-	-
Enterprise Value (EV) ¹	9,107	5,028	8,375	5,898	5,898	5,898
P/E ratio	42.2 x	40.4 x	36.5 x	21.7 x	17.7 x	14.6 x
Yield	0.67%	0.75%	0.99%	1.64%	2.02%	2.25%
Capitalization / Revenue	17.4 x	10.3 x	11.2 x	6.53 x	5.33 x	4.43 x
EV / Revenue	17.4 x	10.3 x	11.2 x	6.53 x	5.33 x	4.43 x
EV / EBITDA	-	32.8 x	31.8 x	18.1 x	15 x	12.2 x
EV / FCF	-	-	-	-30.6 x	-70.2 x	19.2 x
FCF Yield	-	-	-	-3.27%	-1.42%	5.21%
Price to Book	4.71 x	2.65 x	4.07 x	2.63 x	2.37 x	2.12 x
Nbr of stocks (in thousands)	160,000	157,726	157,153	157,109	-	-
Reference price ²	56.92	31.88	53.29	37.54	37.54	37.54
Announcement Date	2/22/22	2/10/23	2/21/24	-	-	-

¹CNY in Million²CNY

Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	-	523.5	488.5	744.8	903.1	1,106	1,333
EBITDA ¹	-	-	153.2	263.5	325	394	483
EBIT ¹	-	224.1	135.5	247.4	301.7	372	452.7
Operating Margin	-	42.8%	27.73%	33.22%	33.4%	33.65%	33.96%
Earnings before Tax (EBT) ¹	-	222.7	133	246.8	301	371.3	451.7
Net income ¹	196.3	201.9	125.5	229.6	277.4	339.4	412
Net margin	-	38.57%	25.68%	30.82%	30.71%	30.7%	30.91%
EPS ²	1.640	1.350	0.7900	1.460	1.733	2.120	2.573
Free Cash Flow ¹	-	-	-	-	-193	-84	307
FCF margin	-	-	-	-	-21.37%	-7.6%	23.03%
FCF Conversion (EBITDA)	-	-	-	-	-	-	63.56%
FCF Conversion (Net income)	-	-	-	-	-	-	74.52%
Dividend per Share ²	-	0.3800	0.2400	0.5300	0.6150	0.7600	0.8450
Announcement Date	4/28/21	2/22/22	2/10/23	2/21/24	-	-	-

¹CNY in Million²CNY

Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December	2024 Q1
Net sales ¹	169.1
EBITDA	-
EBIT	-
Operating Margin	-
Earnings before Tax (EBT)	-
Net income ¹	39.07
Net margin	23.11%
EPS	-
Dividend per Share	-
Announcement Date	4/17/24

¹CNY in Million

Estimates

Balance Sheet Analysis

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026
Net Debt	-	-	-	-	-	-	-
Net Cash position	-	-	-	-	-	-	-
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-
Free Cash Flow ¹	-	-	-	-	-193	-84	307
ROE (net income / shareholders' equity)	-	12.6%	6.53%	11.4%	12.1%	13.3%	14.7%
ROA (Net income/ Total Assets)	-	12.7%	5.51%	9.23%	9.68%	10.4%	11.3%
Assets ¹	-	1,586	2,275	2,488	2,865	3,272	3,639
Book Value Per Share ²	-	12.10	12.00	13.10	14.30	15.80	17.70
Cash Flow per Share ²	-	1.040	1.170	1.420	1.860	2.270	2.800
Capex ¹	-	134	203	479	310	307	144
Capex / Sales	-	25.57%	41.55%	64.33%	34.36%	27.8%	10.83%
Announcement Date	4/28/21	2/22/22	2/10/23	2/21/24	-	-	-

¹CNY in Million²CNY

Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Xiangyu Medical Co.,Ltd

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

37.54 CNY

Average target price

48.78 CNY

Spread / Average Target

+29.94%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
XIANGYU MEDICAL CO.,LTD	-29.56%	817M
THERMO FISHER SCIENTIFIC	+12.85%	229B
DANAHER CORPORATION	+13.88%	195B
INTUITIVE SURGICAL, INC.	+18.39%	142B
BOSTON SCIENTIFIC CORPORATION	+28.78%	109B
SIEMENS HEALTHINEERS AG	+1.67%	64.85B
EDWARDS LIFESCIENCES CORPORATION	+18.24%	54.33B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+7.04%	52.09B
AGILENT TECHNOLOGIES, INC.	+10.83%	45.15B
GE HEALTHCARE TECHNOLOGIES INC.	+5.94%	37.39B

Other Advanced Medical Equipment & Technology